EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $495,000 | -89.7% | 15,945 | -80.3% | 0.00% | -92.3% |
Q4 2018 | $4,807,000 | +33.3% | 81,093 | +48.0% | 0.01% | +62.5% |
Q3 2018 | $3,607,000 | +162.7% | 54,800 | +101.5% | 0.01% | +166.7% |
Q2 2018 | $1,373,000 | -54.0% | 27,192 | -52.1% | 0.00% | -57.1% |
Q1 2018 | $2,988,000 | -64.6% | 56,761 | -80.4% | 0.01% | -77.4% |
Q1 2017 | $8,429,000 | – | 290,266 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |